Masaru Matsuda - SVP, General Counsel at HALOZYME THERAPEUTICS, INC.

Issuer-level insider activity

Role
SVP, General Counsel
Issuer ticker
HALO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Masaru Matsuda since 20 Sep 2025

Reported holdings for Masaru Matsuda in HALOZYME THERAPEUTICS, INC.

Form 4 holding SVP, General Counsel

HALOZYME THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
20,049
Estimated value
$721,764
Report date
04 Sep 2021
Price
$36.00
Ownership
Direct
Form 4 holding SVP, General Counsel

HALOZYME THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
6,883
Estimated value
$278,032
Report date
04 Sep 2021
Price
$40.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Masaru Matsuda in HALOZYME THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .